Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.
Rosetting is a Plasmodium falciparum virulence factor implicated in the pathogenesis of life-threatening malaria. Rosetting occurs when parasite-derived P. falciparum Erythrocyte Membrane Protein One (PfEMP1) on the surface of infected erythrocytes binds to human receptors on uninfected erythrocytes...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3031562?pdf=render |
id |
doaj-37b08c9735ed468d8c450183348e8c83 |
---|---|
record_format |
Article |
spelling |
doaj-37b08c9735ed468d8c450183348e8c832020-11-25T00:07:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0161e1641410.1371/journal.pone.0016414Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.Ashfaq GhumraPongsak KhunraeRicardo AtaideAhmed RazaStephen J RogersonMatthew K HigginsJ Alexandra RoweRosetting is a Plasmodium falciparum virulence factor implicated in the pathogenesis of life-threatening malaria. Rosetting occurs when parasite-derived P. falciparum Erythrocyte Membrane Protein One (PfEMP1) on the surface of infected erythrocytes binds to human receptors on uninfected erythrocytes. PfEMP1 is a possible target for a vaccine to induce antibodies to inhibit rosetting and prevent severe malaria.We examined the vaccine potential of the six extracellular domains of a rosette-mediating PfEMP1 variant (ITvar9/R29var1 from the R29 parasite strain) by immunizing rabbits with recombinant proteins expressed in E. coli. Antibodies raised to each domain were tested for surface fluorescence with live infected erythrocytes, rosette inhibition and phagocytosis-induction. Antibodies to all PfEMP1 domains recognized the surface of live infected erythrocytes down to low concentrations (0.02-1.56 µg/ml of total IgG). Antibodies to all PfEMP1 domains except for the second Duffy-Binding-Like region inhibited rosetting (50% inhibitory concentration 0.04-4 µg/ml) and were able to opsonize and induce phagocytosis of infected erythrocytes at low concentrations (1.56-6.25 µg/ml). Antibodies to the N-terminal region (NTS-DBL1α) were the most effective in all assays. All antibodies were specific for the R29 parasite strain, and showed no functional activity against five other rosetting strains.These results are encouraging for vaccine development as they show that potent antibodies can be generated to recombinant PfEMP1 domains that will inhibit rosetting and induce phagocytosis of infected erythrocytes. However, further work is needed on rosetting mechanisms and cross-reactivity in field isolates to define a set of PfEMP1 variants that could induce functional antibodies against a broad range of P. falciparum rosetting parasites.http://europepmc.org/articles/PMC3031562?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ashfaq Ghumra Pongsak Khunrae Ricardo Ataide Ahmed Raza Stephen J Rogerson Matthew K Higgins J Alexandra Rowe |
spellingShingle |
Ashfaq Ghumra Pongsak Khunrae Ricardo Ataide Ahmed Raza Stephen J Rogerson Matthew K Higgins J Alexandra Rowe Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum. PLoS ONE |
author_facet |
Ashfaq Ghumra Pongsak Khunrae Ricardo Ataide Ahmed Raza Stephen J Rogerson Matthew K Higgins J Alexandra Rowe |
author_sort |
Ashfaq Ghumra |
title |
Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum. |
title_short |
Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum. |
title_full |
Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum. |
title_fullStr |
Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum. |
title_full_unstemmed |
Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum. |
title_sort |
immunisation with recombinant pfemp1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to plasmodium falciparum. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2011-01-01 |
description |
Rosetting is a Plasmodium falciparum virulence factor implicated in the pathogenesis of life-threatening malaria. Rosetting occurs when parasite-derived P. falciparum Erythrocyte Membrane Protein One (PfEMP1) on the surface of infected erythrocytes binds to human receptors on uninfected erythrocytes. PfEMP1 is a possible target for a vaccine to induce antibodies to inhibit rosetting and prevent severe malaria.We examined the vaccine potential of the six extracellular domains of a rosette-mediating PfEMP1 variant (ITvar9/R29var1 from the R29 parasite strain) by immunizing rabbits with recombinant proteins expressed in E. coli. Antibodies raised to each domain were tested for surface fluorescence with live infected erythrocytes, rosette inhibition and phagocytosis-induction. Antibodies to all PfEMP1 domains recognized the surface of live infected erythrocytes down to low concentrations (0.02-1.56 µg/ml of total IgG). Antibodies to all PfEMP1 domains except for the second Duffy-Binding-Like region inhibited rosetting (50% inhibitory concentration 0.04-4 µg/ml) and were able to opsonize and induce phagocytosis of infected erythrocytes at low concentrations (1.56-6.25 µg/ml). Antibodies to the N-terminal region (NTS-DBL1α) were the most effective in all assays. All antibodies were specific for the R29 parasite strain, and showed no functional activity against five other rosetting strains.These results are encouraging for vaccine development as they show that potent antibodies can be generated to recombinant PfEMP1 domains that will inhibit rosetting and induce phagocytosis of infected erythrocytes. However, further work is needed on rosetting mechanisms and cross-reactivity in field isolates to define a set of PfEMP1 variants that could induce functional antibodies against a broad range of P. falciparum rosetting parasites. |
url |
http://europepmc.org/articles/PMC3031562?pdf=render |
work_keys_str_mv |
AT ashfaqghumra immunisationwithrecombinantpfemp1domainselicitsfunctionalrosetteinhibitingandphagocytosisinducingantibodiestoplasmodiumfalciparum AT pongsakkhunrae immunisationwithrecombinantpfemp1domainselicitsfunctionalrosetteinhibitingandphagocytosisinducingantibodiestoplasmodiumfalciparum AT ricardoataide immunisationwithrecombinantpfemp1domainselicitsfunctionalrosetteinhibitingandphagocytosisinducingantibodiestoplasmodiumfalciparum AT ahmedraza immunisationwithrecombinantpfemp1domainselicitsfunctionalrosetteinhibitingandphagocytosisinducingantibodiestoplasmodiumfalciparum AT stephenjrogerson immunisationwithrecombinantpfemp1domainselicitsfunctionalrosetteinhibitingandphagocytosisinducingantibodiestoplasmodiumfalciparum AT matthewkhiggins immunisationwithrecombinantpfemp1domainselicitsfunctionalrosetteinhibitingandphagocytosisinducingantibodiestoplasmodiumfalciparum AT jalexandrarowe immunisationwithrecombinantpfemp1domainselicitsfunctionalrosetteinhibitingandphagocytosisinducingantibodiestoplasmodiumfalciparum |
_version_ |
1725418091464097792 |